Lightpoint Medical Receives CE Mark for World's First Approved Robotic Gamma Probe
Lightpoint Medical Receives CE Mark for World's First Approved Robotic Gamma Probe News provided by Share this article Share this article CHESHAM, England, Jan. 20, 2021 /PRNewswire/ -- Lightpoint Medical, a medical device company developing miniaturized surgical tools for advanced intra-operative cancer detection, announced today that it has received CE Mark approval for SENSEI®, the first robotic gamma probe to be commercially available to European hospital systems. Lightpoint Medical Receives CE Mark for World’s First Approved Robotic Gamma Probe SENSEI® has been designed for intra-op...
Source: prnewswire.com